Departments of Otolaryngology-Head and Neck Surgery and Neurological Surgery, University of California, Irvine, Orange, California, USA.
Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Int Forum Allergy Rhinol. 2024 Feb;14(2):149-608. doi: 10.1002/alr.23262. Epub 2024 Jan 2.
Sinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represent a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors (ICSNT) aims to summarize the best available evidence and presents 48 thematic and histopathology-based topics spanning the field.
In accordance with prior International Consensus Statement on Allergy and Rhinology documents, ICSNT assigned each topic as an Evidence-Based Review with Recommendations, Evidence-Based Review, and Literature Review based on the level of evidence. An international group of multidisciplinary author teams were assembled for the topic reviews using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses format, and completed sections underwent a thorough and iterative consensus-building process. The final document underwent rigorous synthesis and review prior to publication.
The ICSNT document consists of four major sections: general principles, benign neoplasms and lesions, malignant neoplasms, and quality of life and surveillance. It covers 48 conceptual and/or histopathology-based topics relevant to sinonasal neoplasms and masses. Topics with a high level of evidence provided specific recommendations, while other areas summarized the current state of evidence. A final section highlights research opportunities and future directions, contributing to advancing knowledge and community intervention.
As an embodiment of the multidisciplinary and collaborative model of care in sinonasal neoplasms and masses, ICSNT was designed as a comprehensive, international, and multidisciplinary collaborative endeavor. Its primary objective is to summarize the existing evidence in the field of sinonasal neoplasms and masses.
无论是良性还是恶性的鼻窦肿瘤，都对临床医生构成了重大挑战，也是多学科合作以优化患者治疗的典范领域。《过敏与鼻科学国际共识声明：鼻窦肿瘤》（ICSNT）旨在总结现有最佳证据，并提出涵盖该领域的 48 个专题和组织病理学主题。
根据先前的《过敏与鼻科学国际共识声明》文件，ICSNT 根据证据级别将每个主题分为基于证据的综述和推荐、基于证据的综述和文献综述。使用系统评价和荟萃分析首选报告项目的格式，为主题审查组建了一个国际多学科作者团队，并完成了经过彻底和反复的共识制定过程的章节。在发布之前，最终文件进行了严格的综合和审查。
ICSNT 文件由四个主要部分组成：一般原则、良性肿瘤和病变、恶性肿瘤以及生活质量和监测。它涵盖了与鼻窦肿瘤和肿块相关的 48 个基于概念和/或组织病理学的主题。具有高证据水平的主题提供了具体建议，而其他领域则总结了现有证据的状况。最后一部分突出了研究机会和未来方向，有助于推进知识和社区干预。
作为鼻窦肿瘤和肿块多学科和协作护理模式的体现，ICSNT 旨在成为一项全面、国际化和多学科合作的努力。其主要目标是总结鼻窦肿瘤和肿块领域的现有证据。
